{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:45:57Z","timestamp":1782708357274,"version":"3.54.5"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Immune deficiency and infection with human herpesvirus-8 (HHV-8) are established component causes of Kaposi sarcoma (KS), but they are insufficient to cause disease in most people at risk. Therefore, we hypothesized that genetic variation may contribute to KS risk in children and adults, as well as contribute to its unique epidemiology in sub-Saharan Africa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To test this hypothesis, we conducted a two-phase genome-wide association study (GWAS): a discovery study in perinatally HIV-infected children (45 KS cases, 91 controls), followed by validation of significant results in a sample of adults living with HIV (215 cases, 262 controls). After standard quality control, we tested single-nucleotide variants for association with KS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In children, the top signal was a missense variant in the mitochondrial antiviral-signaling (\n                      <jats:italic>MAVS<\/jats:italic>\n                      ) gene (rs7269320), which showed a suggestive allelic association with KS (OR 3.8, 95% CI 2.2 -6.7, p=9.7\u00d710\n                      <jats:sup>-7<\/jats:sup>\n                      ). In the adult validation study, the same MAVS variant was again associated with KS, indicating a recessive inheritance pattern (OR 2.2, 95% CI 1.2 -3.9, p=0.006).\n                      <jats:italic>MAVS<\/jats:italic>\n                      is a component of the RIG-I\/MAVS signaling pathway and a biologically plausible genetic variant contributing to KS oncogenesis. MAVS protein deficiency\/dysfunction is known to impair the antiviral cytokine response to HHV-8 infection and enhance its reactivation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      These findings provide the first pediatric evidence of germline susceptibility to KS and suggest RIG-I\/MAVS as a candidate pathway for host risk. Further replication and functional studies are needed to clarify the mechanism underlying the risk associated with\n                      <jats:italic>MAVS<\/jats:italic>\n                      and to assess whether it could be used to identify individuals at the highest risk for KS in high-burden settings and\/or be leveraged as a novel therapeutic strategy.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1796311","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:25:56Z","timestamp":1782707156000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Genome-wide association study identifies and validates genetic variation in the RIG-I\/MAVS signaling pathway associated with HIV-related Kaposi sarcoma in children and adults"],"prefix":"10.3389","volume":"16","author":[{"given":"Casey L.","family":"McAtee","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Baylor College of Medicine","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Peckham-Gregory","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baylor College of Medicine","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pagna","family":"Sok","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baylor College of Medicine","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Richard","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baylor College of Medicine","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Olivares","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baylor College of Medicine","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Marquez-Do","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baylor College of Medicine","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Kisitu","sequence":"additional","affiliation":[{"name":"Baylor Children\u2019s Foundation Uganda","place":["Kampala, Uganda"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California San Francisco","place":["San Francisco, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader Kim","family":"El-Mallawany","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baylor College of Medicine","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl E.","family":"Allen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baylor College of Medicine","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Lubega","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baylor College of Medicine","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Scheurer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baylor College of Medicine","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0000000000001567","article-title":"HIV-associated Kaposi sarcoma and related diseases","volume":"31","author":"Gon\u00e7alves","year":"2017","journal-title":"Aids"},{"key":"B2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/phmt.s142816","article-title":"Pediatric Kaposi sarcoma in context of the HIV epidemic in sub-Saharan Africa: current perspectives","volume":"9","author":"El-Mallawany","year":"2018","journal-title":"Pediatr Heal Med Ther"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiq092","article-title":"Human herpesvirus 8 infection in children and adults in a population-based study in rural Uganda","volume":"203","author":"Butler","year":"2011","journal-title":"J Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26021","article-title":"Mapping the epidemiology of kaposi sarcoma and non\u2010Hodgkin lymphoma among children in sub\u2010Saharan africa: A review","volume":"63","author":"Rees","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(19)30273-6","article-title":"Global childhood cancer survival estimates and priority-setting: a simulation-based analysis","volume":"20","author":"Ward","year":"2019","journal-title":"Lancet Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061379","article-title":"Association between antiretroviral therapy and cancers among children living with HIV in sub-saharan africa","volume":"13","author":"Haq","year":"2021","journal-title":"Cancers"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25235","article-title":"Substantial regional differences in human herpesvirus 8 seroprevalence in sub\u2010Saharan Africa: Insights on the origin of the \u201cKaposi\u2019s sarcoma belt","volume":"127","author":"Dollard","year":"2010","journal-title":"Int J Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0b013e3283498115","article-title":"Prevalence and outcome of HIV-associated Malignancies among children","volume":"25","author":"Tukei","year":"2011","journal-title":"Aids"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22903","article-title":"Kaposi sarcoma in South African children","volume":"56","author":"Stefan","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.02.019","article-title":"Kaposi\u2019s sarcoma in children: An open randomised trial of vincristine, oral etoposide and a combination of vincristine and bleomycin","volume":"50","author":"Chagaluka","year":"2014","journal-title":"Eur J Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13027-018-0207-4","article-title":"Endemic Kaposi sarcoma in HIV-negative children and adolescents: an evaluation of overlapping and distinct clinical features in comparison with HIV-related disease","volume":"13","author":"El-Mallawany","year":"2018","journal-title":"Infect Agents Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2010.116","article-title":"Data quality control in genetic case-control association studies","volume":"5","author":"Anderson","year":"2010","journal-title":"Nat Protoc"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/jhered\/esv059","article-title":"XWAS: A software toolset for genetic data analysis and association studies of the X chromosome","volume":"106","author":"Gao","year":"2015","journal-title":"J Hered"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/ng1847","article-title":"Principal components analysis corrects for stratification in genome-wide association studies","volume":"38","author":"Price","year":"2006","journal-title":"Nat Genet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30241","article-title":"Family\u2010based exome\u2010wide assessment of maternal genetic effects on susceptibility to childhood B\u2010cell acute lymphoblastic leukemia in hispanics","volume":"122","author":"Archer","year":"2016","journal-title":"Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-08-800565","article-title":"A genome-wide association study of LCH identifies a variant in SMAD6 associated with susceptibility","volume":"130","author":"Peckham-Gregory","year":"2017","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2010.182","article-title":"Basic statistical analysis in genetic case-control studies","volume":"6","author":"Clarke","year":"2011","journal-title":"Nat Protoc"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113684","article-title":"Accounting for eXentricities: analysis of the X chromosome in GWAS reveals X-linked genes implicated in autoimmune diseases","volume":"9","author":"Chang","year":"2014","journal-title":"PloS One"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr917","article-title":"HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants","volume":"40","author":"Ward","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1089\/gtmb.2010.0036","article-title":"Using SIFT and polyPhen to predict loss-of-function and gain-of-function mutations","volume":"14","author":"Flanagan","year":"2010","journal-title":"Genet Test Mol Bioma"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1086\/519795","article-title":"PLINK: A tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"B22","unstructured":"R: A Language and Environment for Statistical Computing\n          \n          \n          \n          2025"},{"key":"B23","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/qai.0000000000000747","article-title":"The kynurenine pathway of tryptophan catabolism and AIDS-associated kaposi sarcoma in africa","volume":"70","author":"Byakwaga","year":"2015","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1101\/2023.07.21.23292658","article-title":"Impact of kaposi sarcoma on quality of life amongst HIV-infected adults initiating antiretroviral therapy in east africa","author":"Scott","year":"2023","journal-title":"medRxiv"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0b013e328363b53f","article-title":"Realtime adherence monitoring of antiretroviral therapy among hiv-infected adults and children in rural Uganda","volume":"27","author":"Haberer","year":"2013","journal-title":"AIDS"},{"key":"B26","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1089\/aid.2014.0043","article-title":"Prevalence and virologic consequences of transmitted HIV-1 drug resistance in Uganda","volume":"30","author":"Lee","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2018.0020","article-title":"Increasing prevalence of HIV pretreatment drug resistance in women but not men in rural Uganda during 2005\u20132013","volume":"32","author":"McCluskey","year":"2018","journal-title":"AIDS Patient Care STDs"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.03226-13","article-title":"An important role for mitochondrial antiviral signaling protein in the kaposi\u2019s sarcoma-associated herpesvirus life cycle","volume":"88","author":"West","year":"2014","journal-title":"J Virol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01903-15","article-title":"Modulation of mitochondrial antiviral signaling by human herpesvirus 8 interferon regulatory factor 1","volume":"90","author":"Hwang","year":"2015","journal-title":"J Virol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: the NCBI database of genetic variation","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201000120","article-title":"A loss\u2010of\u2010function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients","volume":"3","author":"Pothlichet","year":"2011","journal-title":"EMBO Mol Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151173","article-title":"Alteration of antiviral signalling by single nucleotide polymorphisms (SNPs) of mitochondrial antiviral signalling protein (MAVS)","volume":"11","author":"Xing","year":"2016","journal-title":"PloS One"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007058","article-title":"Peroxisomes support human herpesvirus 8 latency by stabilizing the viral oncogenic protein vFLIP via the MAVS-TRAF complex","volume":"14","author":"Choi","year":"2018","journal-title":"PloS Pathog"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.08.012","article-title":"Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-\u03baB and IRF3","volume":"122","author":"Seth","year":"2005","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd0276","article-title":"PPM1G restricts innate immune signaling mediated by STING and MAVS and is hijacked by KSHV for immune evasion","volume":"6","author":"Yu","year":"2020","journal-title":"Sci Adv"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-025-02018-3","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus induces mitochondrial fission to evade host immune responses and promote viral production","volume":"10","author":"Zhu","year":"2025","journal-title":"Nat Microbiol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1172\/jci84418","article-title":"Kaposi sarcoma\u2013associated herpesvirus: immunobiology, oncogenesis, and therapy","volume":"126","author":"Dittmer","year":"2016","journal-title":"J Clin Invest"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2026.02.027","article-title":"Human retinoic acid\u2013inducible gene I deficiency is associated with susceptibility to classic Kaposi sarcoma","author":"Roussel","year":"2026","journal-title":"J Allergy Clin Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2160","article-title":"Evidence for altered host genetic factors in KSHV infection and KSHV\u2010related disease development","volume":"31","author":"Blumenthal","year":"2021","journal-title":"Rev Med Virol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(08)70175-x","article-title":"Part I: Cancer in Indigenous Africans\u2014burden, distribution, and trends","volume":"9","author":"Parkin","year":"2008","journal-title":"Lancet Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-3-11","article-title":"HHV-8 seroprevalence: a global view","volume":"3","author":"Rohner","year":"2014","journal-title":"Syst Rev"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/qai.0000000000000360","article-title":"Incidence rate of kaposi sarcoma in HIV-infected patients on antiretroviral therapy in southern africa","volume":"67","author":"Rohner","year":"2014","journal-title":"Jaids J Acquir Immune Defic Syndromes"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2014.02.006","article-title":"Risk factors for Kaposi\u2019s sarcoma among HIV-positive individuals in a case control study in Cameroon","volume":"38","author":"Stolka","year":"2014","journal-title":"Cancer Epidemiol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34454","article-title":"Kaposi sarcoma\u2010associated herpesvirus, HIV\u20101 and Kaposi sarcoma risk in black South Africans diagnosed with cancer during antiretroviral treatment rollout","volume":"152","author":"Motlhale","year":"2023","journal-title":"Int J Cancer"},{"key":"B46","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/hiv.13191","article-title":"Long\u2010term outcomes for children and adolescents with Kaposi sarcoma","volume":"23","author":"Silverstein","year":"2022","journal-title":"HIV Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.167854","article-title":"Pediatric HIV+ Kaposi sarcoma exhibits clinical, virological, and molecular features different from the adult disease","volume":"8","author":"Caro-Vegas","year":"2023","journal-title":"JCI Insight"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70169-i","article-title":"Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi\u2019s sarcoma","volume":"22","author":"Friedman-Kien","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1097\/inf.0b013e3181691740","article-title":"Human herpesvirus 8 seroprevalence among children and adolescents in the United States","volume":"27","author":"Anderson","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v96.7.2562.h8002562_2562_2567","article-title":"An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus","volume":"96","author":"Foster","year":"2000","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/s0198-8859(01)00247-6","article-title":"Analysis of the distribution of HLA-B alleles in populations from five continents","volume":"62","author":"Williams","year":"2001","journal-title":"Hum Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1086\/386308","article-title":"Familial clustering of classic Kaposi sarcoma","volume":"189","author":"Guttman\u2010Yassky","year":"2004","journal-title":"J Infect Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20101597","article-title":"Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma","volume":"207","author":"Byun","year":"2010","journal-title":"J Exp Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130592","article-title":"Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood","volume":"210","author":"Byun","year":"2013","journal-title":"J Exp Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2014.42","article-title":"SNP screening of central MHC-identified HLA-DMB as a candidate susceptibility gene for HIV-related Kaposi\u2019s sarcoma","volume":"15","author":"Aissani","year":"2014","journal-title":"Genes Immun"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.23066","article-title":"Age of onset and effect size in genome\u2010wide association studies","volume":"94","author":"Agopian","year":"2012","journal-title":"Birth Defects Res Part Clin Mol Teratol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00391","article-title":"Immunity to HIV in early life","volume":"5","author":"Muenchhoff","year":"2014","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/s2214-109x(16)30143-7","article-title":"Global burden of cancers attributable to infections in 2012: a synthetic analysis","volume":"4","author":"Plummer","year":"2016","journal-title":"Lancet Glob Heal"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(196007\/08)13:4<684::aid-cncr2820130408>3.0.co;2-g","article-title":"Kaposi\u2019s sarcoma in infants and children","volume":"13","author":"Dutz","year":"1960","journal-title":"Cancer"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24516","article-title":"Clinical characteristics and outcomes of HIV\u2010infected children diagnosed with kaposi sarcoma in Malawi and Botswana","volume":"60","author":"Cox","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26841","article-title":"Triple therapy of vincristine, bleomycin and etoposide for children with Kaposi sarcoma: Results of a study in Malawian children","volume":"65","author":"Macken","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1606701","article-title":"Mapping Plasmodium falciparum mortality in Africa between 1990 and 2015","volume":"375","author":"Gething","year":"2016","journal-title":"N Engl J Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076711","article-title":"Distinctive Kaposi sarcoma-associated herpesvirus serological profile during acute Plasmodium falciparum malaria episodes","volume":"24","author":"Oluoch","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad308","article-title":"Plasmodium falciparum malaria is associated with increased Kaposi sarcoma\u2013associated herpesvirus (KSHV) seropositivity and higher KSHV antibody breadth and magnitude: Results of a case-control study from rural Uganda","volume":"229","author":"Nalwoga","year":"2023","journal-title":"J Infect Dis"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/nature04193","article-title":"Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus","volume":"437","author":"Meylan","year":"2005","journal-title":"Nature"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2009.07.001","article-title":"Degradation of RIG-I following cytomegalovirus infection is independent of apoptosis","volume":"11","author":"Scott","year":"2009","journal-title":"Microbes Infect"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903874","article-title":"The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein","volume":"185","author":"Wei","year":"2010","journal-title":"J Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01737-17","article-title":"The human papillomavirus E6 oncoprotein targets USP15 and TRIM25 to suppress RIG-I-mediated innate immune signaling","volume":"92","author":"Chiang","year":"2018","journal-title":"J Virol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011186","article-title":"Suppression of cGAS- and RIG-I-mediated innate immune signaling by Epstein-Barr virus deubiquitinase BPLF1","volume":"19","author":"Lui","year":"2023","journal-title":"PloS Pathog"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(11)61177-x","article-title":"Burkitt\u2019s lymphoma","volume":"379","author":"Molyneux","year":"2012","journal-title":"Lancet"},{"key":"B71","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: Triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae404","article-title":"Similar viral and immune characteristics of Kaposi sarcoma in ART-treated people living with HIV and older patients with classic Kaposi sarcoma","volume":"11","author":"Royston","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ996","article-title":"Clinical features and outcomes of patients with symptomatic Kaposi sarcoma herpesvirus (KSHV)-associated inflammation: Prospective characterization of KSHV inflammatory cytokine syndrome (KICS)","volume":"62","author":"Polizzotto","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1796311\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:25:59Z","timestamp":1782707159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1796311\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":73,"alternative-id":["10.3389\/fonc.2026.1796311"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1796311","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"article-number":"1796311"}}